Share
Market Research Report

ASTHMA AND COPD MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Drug TypeBronchodilators (Short Acting Bronchodilators, Long Acting Bronchodilators) · Anti-Inflammatories (Inhaled Corticosteroids, Leukotriene Modulators and Others) · Combination Therapies
  • By Disease TypeAsthma · and COPD
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • Published In27 Apr 2026
  • Report CodeCMI4002
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug Type
      • Market Snapshot, By Disease Type
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Recent Product Launches
    • Epidemiology
    • Merger, Acquisition, and Collaborations
    • Regulatory Scenario
    • Key Developments
    • PEST Analysis
  4. Global Asthma And COPD Market, By Drug Type, 2021–2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    •  Bronchodilators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
      • Short Acting Bronchodilators
      • Long Acting Bronchodilators
    •  Anti-Inflammatories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
      • Inhaled Corticosteroids
      • Leukotriene Modulators
      • Others
    • Combination Therapies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  5. Global Asthma And COPD Market, By Disease Type, 2021–2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Asthma
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
    • COPD
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  6. Global Asthma And COPD Market, By Distribution Channel, 2021–2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022–2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Bn)
  7. Global Asthma And COPD Market, By Region, 2021–2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Regions, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021–2033, (US$ Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GSP plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Verona Pharma plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Regeneron Pharmaceuticals Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boehringer Ingelheim International GmbH
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  9. Section

    • Research Methodology
    • About Us

*Browse 34 market data tables and 29 figures on “Asthma and COPD Market”- Global forecast to 2033